Delivery Order 75N95023D00022-75N95023F00001
Award Date 9/20/23
Potential Completion Date 9/19/24
Potential Value $3.9K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Bellefonte, PA 16823, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award is for research and development (R&D) services related to biocompatibility testing, animal studies, and sterilization testing in support of the National Institute on Drug Abuse's (NIDA) Blueprint MedTech (BPMT) Initiative. The $32,848 cost-plus-fixed-fee contract was awarded to Actuated Medical, Inc., a woman-owned small business located in Bellefonte, Pennsylvania. The contract will run from August 18, 2025, to February 17, 2026, and is not a set-aside....
- This is a delivery order issued under a $35 million Indefinite Delivery Contract (IDC) between Actuated Medical, Inc. (a woman-owned small business based in Bellefonte, Pennsylvania) and the National Institute on Drug Abuse (NIDA). The contract supports the Blueprint MedTech (BPMT) Initiative, which aims to develop innovative medical technologies for nervous system disorders. This specific delivery order, valued at $81,702, is for research and development services related to biocompatibility...
- This is a federal contract award to Actuated Medical, Inc., a woman-owned small business located in Bellefonte, Pennsylvania. The contract, valued at $65,696.00, is for research and development services related to biocompatibility testing, animal studies, and sterilization testing in support of the National Institute on Drug Abuse's (NIDA) Blueprint MedTech (BPMT) Initiative. The contract is a delivery order, with a cost-plus-fixed-fee pricing type, and is not set aside. Actuated Medical has...
- This is a $32,848 firm fixed-price delivery order awarded to Actuated Medical, Inc., a woman-owned small business, by the National Institute on Drug Abuse (NIDA). The task order is for research and development services related to biocompatibility testing, animal studies, and sterilization testing for medical technologies, with a period of performance from July 14, 2025 to January 13, 2026. This task order is issued under a larger $35 million Indefinite Delivery Contract (IDC) that supports...
- The National Institute on Drug Abuse (NIDA), part of the National Institutes of Health under the Department of Health and Human Services, awarded a consulting services contract to Layer 5 LLC on December 6, 2024, for subject matter expert support in neurological medical device development under the Blueprint MedTech initiative. The contract, designated as a Total Small Business set-aside with a ceiling value of $49.2K, will be performed in Rockville, Maryland, over a period of performance...
- This federal contract award is for the evaluation of a potential respiratory stimulant on behalf of the National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health (NIH). The award, with a ceiling value of $140,848.00, was issued to Lovelace Biomedical Research Institute, a not-for-profit preclinical contract research organization. The scope of work includes nonclinical animal studies to assess potential treatments for drug-induced respiratory depression and...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a Small Business Innovation Research (SBIR) Program Phase I contract to B & W TEK Inc., a for-profit manufacturing organization, to develop new commercially viable devices, tools, technologies or integrated systems for drug detection and deactivation to deter opioid theft in hospitals. The definitive, firm fixed-price contract has a potential value of $224,656.02 and a...
- The Department of Health and Human Services' National Institutes of Health's National Institute on Drug Abuse awarded a $24,978.26 firm fixed price purchase order to Neuronexus Technologies, Inc., doing business as Nuvectra, for data acquisition printed circuit boards to support scientific research. The contract has a period of performance of September 7, 2023 through September 6, 2024. Place of performance will be Nuvectra's facilities in Baltimore, Maryland. No set aside designation or...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $22,349 purchase order to Pmod Technologies LLC, a subsidiary of Bruker Corporation, to provide pet analysis software. The software will support Dr. Bradberry's research analyzing data from positron emission tomography experiments and is considered a firm fixed price contract. Performance will take place in Baltimore, Maryland over the course of one year beginning in September...
- This is a Cost Plus Fixed Fee contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Medavante, Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase II. The contract, valued at $625,055.25, is for research and development in physical science. The contract has a period of performance through September 16, 2011. This contract is a definitive contract, indicating it is a stand-alone award rather than being associated with a larger...